Hyderabad, 27, February 2023: Granules India Limited announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA)for Losartan Potassium Tablets USP, 25 mg,50 mg, and 100 mg.
It is bioequivalent to the reference listed drug product (RLD), Cozaar Tablets of Organon LLC. Granules now has a total of 54 ANDA approvals from US FDA (52 Final approvals and 2 tentative approvals).
Losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure.
The current annual U.S. market for Losartan potassium Tablets is approximately $336 Million, according to MAT Dec 2022, IQVIA/IMS Health.
Granules India Limited has consistently achieved manufacturing success, set new standards of quality, and expanded its presence across the world.
Bengaluru, India – May 02, 2024 – Agora, Inc.
Gurugram, India – October 11, 2023: Samsung announced exciting offers
Bangalore, 10th October 2023: The Nokia G42 5G (16GB+256G
Bengaluru, October 10, 2023 IN-SPACe (Indian National Space Promotion and
India – April 30, 2024 – Solitario, the premier destination for luxury lab-grown diamo
Mumbai - National, 29th April 2024: Greenply Industries Limited, a pioneer in the interior infrastructu
Bengaluru, 29 April 2024: Zepp Health, a global provider of smart wearables and health technology, has announced the launch o
Kerala / 04-05-2024
Scientists need to check misuse of traditional knowledge: CSIR-NIIST workshop on IPRCorporate / 04-05-2024
CSIR-NIIST opens Innovation Centre for startups Facility to promote tech-driven entrepreneurshipElectronics / 04-05-2024
Samsung to Soon Unveil Galaxy F55 5G with Premium Vegan Leather Finish in IndiaCorporate / 04-05-2024
Manoj Bajpayee Joins the Nand Ghar MovementKerala / 04-05-2024
Kerala startup Alibi Global inks MoU with IIT Bombay Pact enables transfer of Spherical Robot tech for room interventionPelikken © Copyright 2022, All Rights Reserved
